Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Smoking

  Free Subscription


Articles published in Am J Public Health

Retrieve available abstracts of 48 articles:
HTML format



Single Articles


    November 2024
  1. WARNER KE
    Kids No Longer Smoke Cigarettes. Why Aren't We Celebrating?
    Am J Public Health. 2024;114:1191-1194.
    PubMed    


  2. HULTGREN BA, Calhoun BH, Fleming CB, Rhew IC, et al
    Trends in Driving Under the Influence of Alcohol and Cannabis Among Young Adults in Washington State From Before to During the COVID-19 Pandemic.
    Am J Public Health. 2024;114.
    PubMed     Abstract available


    January 2024
  3. FRIEDMAN AS, Pesko MF
    Tobacco 21 Laws and Youth Tobacco Use: The Role of Policy Attributes.
    Am J Public Health. 2024;114:90-97.
    PubMed     Abstract available


  4. VOCI S, Veldhuizen S, Ivanova A, Melamed OC, et al
    Cannabis Use Among Adults in Cigarette Smoking Cessation Treatment in Ontario, Canada: Prevalence and Association With Tobacco Cessation Outcome, 2015-2021.
    Am J Public Health. 2024;114:98-107.
    PubMed     Abstract available


    December 2023
  5. SHARMA S, Babaria P, Tian D, Scott L, et al
    Medi-Cal's Population Health Management Program: Advancing Shared Medicaid and Public Health Data Processes and Infrastructure.
    Am J Public Health. 2023;113:1283-1286.
    PubMed    


    August 2023
  6. MEHROTRA R, Yadav K, Siddiqi K
    Tobacco Dependence in Adolescents: What Lies Ahead?
    Am J Public Health. 2023;113:859-860.
    PubMed    


  7. PERUGA A, Fernandez E
    Addressing Commercial Determinants to End High Tobacco Dependence Among Adolescents.
    Am J Public Health. 2023;113:856-858.
    PubMed    


  8. YANG H, Ma C, Zhao M, Xi B, et al
    Prevalence of and Factors Associated With Tobacco Dependence Among Adolescents Aged 12-16 Years Who Were Currently Smoking Tobacco in 125 Countries or Territories, 2012-2019.
    Am J Public Health. 2023;113:861-869.
    PubMed     Abstract available


    July 2023
  9. PILEHVARI A, You W, Krukowski RA, Little MA, et al
    Examining Smoking Prevalence Disparities in Virginia Counties by Rurality, Appalachian Status, and Social Vulnerability, 2011-2019.
    Am J Public Health. 2023;113:811-814.
    PubMed     Abstract available


    May 2023
  10. GOTTLIEB MA
    To End Youth Vaping as an On-Ramp to Addiction, Close Legal Loopholes and Rigorously Enforce the Law.
    Am J Public Health. 2023;113:472-473.
    PubMed    


  11. AZAGBA S, Ebling T, Adekeye OT, Hall M, et al
    Loopholes for Underage Access in E-Cigarette Delivery Sales Laws, United States, 2022.
    Am J Public Health. 2023;113:568-576.
    PubMed     Abstract available


    July 2022
  12. DASGUPTA N, Morabia A
    Experimental Forum 2: Two Years After the 2020 Food and Drug Administration Guidance on E-Cigarette Flavors.
    Am J Public Health. 2022;112:995-998.
    PubMed    


  13. MCKEE M
    The Case Against Flavors in E-Cigarettes Is Stronger Than Ever.
    Am J Public Health. 2022;112:1003-1004.
    PubMed    


  14. MORABIA A
    Scientific Publishing and the Tobacco Industry.
    Am J Public Health. 2022;112:951.
    PubMed    


  15. HALLINGBERG B
    E-Cigarette Flavors, Devices, and Brand Preferences Among Youths in Canada, England, and the United States: The Value and Challenges of Comparing International Survey Data.
    Am J Public Health. 2022;112:1011-1013.
    PubMed    


  16. HAMMOND D, Reid JL, Burkhalter R, Bansal Travers M, et al
    E-Cigarette Flavors, Devices, and Brands Used by Youths Before and After Partial Flavor Restrictions in the United States: Canada, England, and the United States, 20172020.
    Am J Public Health. 2022;112:1014-1024.
    PubMed     Abstract available


  17. XIE W
    The Food and Drug Administration's e-Cigarette Flavor Restrictions Have Not Gone Far Enough to Curb the Youth e-Cigarette Use Epidemic.
    Am J Public Health. 2022;112:1009-1010.
    PubMed    


  18. MENDELSOHN CP, Wodak A
    Which Regulatory Framework Is Best for Nicotine Vaping?
    Am J Public Health. 2022;112:1001-1002.
    PubMed    


  19. CELESTIN MD, Gee RE
    The Epidemic During the Pandemic: Assessing the Federal Drug Administration's Efforts to Curb Youth Smoking After Passage of HR2339 by Congress.
    Am J Public Health. 2022;112:1005-1006.
    PubMed    


  20. KING BA
    Flavors Remain a Major Driver of Youth E-Cigarette Use.
    Am J Public Health. 2022;112:999-1000.
    PubMed    


  21. SWEANOR D, Houston AR
    Killing Vaping and Americans.
    Am J Public Health. 2022;112:1007-1008.
    PubMed    


    April 2022
  22. TENSO K
    Public Health Students to Fight COVID-19 Worldwide, Not Just at Home.
    Am J Public Health. 2022;112:595-597.
    PubMed    


  23. SUN J, Xi B, Ma C, Zhao M, et al
    Prevalence of E-Cigarette Use and Its Associated Factors Among Youths Aged 12 to 16 Years in 68 Countries and Territories: Global Youth Tobacco Survey, 20122019.
    Am J Public Health. 2022;112:650-661.
    PubMed     Abstract available


  24. SEAMAN EL, Chandora R
    The Importance of Global Youth E-Cigarette Use Surveillance: Opportunities and Next Steps.
    Am J Public Health. 2022;112:541-543.
    PubMed    


    March 2022
  25. MEGHEA CI
    Successful Strategies to Increase Cessation Rates Among Low-Income Maternal Smokers.
    Am J Public Health. 2022;112:351-353.
    PubMed    


  26. COLLINS BN, Lepore SJ, Egleston BL
    Multilevel Intervention for Low-Income Maternal Smokers in the Special Supplemental Nutrition Program for Women, Infants, and Children (WIC).
    Am J Public Health. 2022;112:472-481.
    PubMed     Abstract available


    January 2022
  27. GLANTZ SA
    E-Cigarettes as Consumer Products.
    Am J Public Health. 2022;112:e4-e5.
    PubMed    


    September 2021
  28. SAMET JM, Barrington-Trimis J
    E-Cigarettes and Harm Reduction: An Artificial Controversy Instead of Evidence and a Well-Framed Decision Context.
    Am J Public Health. 2021;111:1572-1574.
    PubMed    


  29. BUSCH AM, Conroy D, Pagoto SL
    Reaching Intermittent Tobacco Users With Technology: New Evidence.
    Am J Public Health. 2021;111:1567-1569.
    PubMed    


  30. DOCKRELL M, Newton JN
    Tobacco Control Leaders Call for a Balanced Assessment of the Risks and Benefits of Nicotine Vaping.
    Am J Public Health. 2021;111:1570-1571.
    PubMed    


  31. MAYS D, Johnson AC, Phan L, Sanders C, et al
    Tailored Mobile Messaging Intervention for Waterpipe Tobacco Cessation in Young Adults: A Randomized Trial.
    Am J Public Health. 2021;111:1686-1695.
    PubMed     Abstract available


  32. BALFOUR DJK, Benowitz NL, Colby SM, Hatsukami DK, et al
    Balancing Consideration of the Risks and Benefits of E-Cigarettes.
    Am J Public Health. 2021;111:1661-1672.
    PubMed     Abstract available


    June 2021
  33. KRESLAKE JM, Simard BJ, O'Connor KM, Patel M, et al
    E-Cigarette Use Among Youths and Young Adults During the COVID-19 Pandemic: United States, 2020.
    Am J Public Health. 2021;111:1132-1140.
    PubMed     Abstract available


    April 2021
  34. ROMER D
    Brazil's Efforts to Reduce Cigarette Use Illustrate Both the Potential Successes and Challenges of This Goal.
    Am J Public Health. 2021;111:549-550.
    PubMed    


  35. MAIA EG, Stopa SR, de Oliveira Santos R, Claro RM, et al
    Trends in Prevalence of Cigarette Smoking in Brazil: 2006-2019.
    Am J Public Health. 2021;111:730-738.
    PubMed     Abstract available


    March 2021
  36. JAUHO M
    The North Karelia Project (1972-1997) and the Origins of the Community Approach to Cardiovascular Disease Prevention.
    Am J Public Health. 2021 Mar 18:e1-e6. doi: 10.2105/AJPH.2020.306016.
    PubMed     Abstract available


  37. SIRCAR NR, Glantz SA
    Defeating JUUL's Effort to Rewrite San Francisco's E-Cigarette Regulations.
    Am J Public Health. 2021;111:457-464.
    PubMed     Abstract available


    February 2021
  38. FAIRCHILD AL
    Is Good Enough Good Enough? E-Cigarettes, Evidence, and Policy.
    Am J Public Health. 2021;111:221-223.
    PubMed    


  39. MAYO-WILSON E
    Should E-Cigarette Regulation Be Based on Randomized Trials or Observational Studies?
    Am J Public Health. 2021;111:219-220.
    PubMed    


  40. GEE RE, Boles WR, Smith DG
    E-Cigarettes: A Public Health Threat, Not a Population Health Intervention.
    Am J Public Health. 2021;111:224-226.
    PubMed    


  41. GRANT S
    Reporting Certainty of Evidence on E-Cigarette Use for Adult Smoking Cessation.
    Am J Public Health. 2021;111:227-229.
    PubMed    


  42. WANG RJ, Bhadriraju S, Glantz SA
    E-Cigarette Use and Adult Cigarette Smoking Cessation: A Meta-Analysis.
    Am J Public Health. 2021;111:230-246.
    PubMed     Abstract available


    December 2020
  43. KENT EE
    Time to Recognize and Support Emerging Adult Caregivers in Public Health.
    Am J Public Health. 2020;110:1720-1721.
    PubMed    


  44. GRENARD DL, Valencia EJ, Brown JA, Winer RL, et al
    Impact of Caregiving During Emerging Adulthood on Frequent Mental Distress, Smoking, and Drinking Behaviors: United States, 2015-2017.
    Am J Public Health. 2020;110:1853-1860.
    PubMed     Abstract available


    November 2020
  45. HOLINGUE C, Kalb LG, Riehm KE, Bennett D, et al
    Mental Distress in the United States at the Beginning of the COVID-19 Pandemic.
    Am J Public Health. 2020;110:1628-1634.
    PubMed     Abstract available


    October 2020
  46. REDDON H, DeBeck K, Socias ME, Lake S, et al
    Frequent Cannabis Use and Cessation of Injection of Opioids, Vancouver, Canada, 2005-2018.
    Am J Public Health. 2020;110:1553-1560.
    PubMed     Abstract available


    September 2020
  47. HALL WD, Leung J
    Short-Term Effects of State Legalization on Adolescent Cannabis Use May Not Predict Any Longer-Term Effects.
    Am J Public Health. 2020;110:1270-1271.
    PubMed    


  48. MIECH R
    Marijuana Legalization and Marijuana Prevalence Among Adolescents.
    Am J Public Health. 2020;110:1268-1269.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Smoking is free of charge.